Henry's Farm Inc. Recalls Soybean Sprouts Due to Possible Health Risk
Henry’s Farm Inc. of Woodford, VA is recalling all packages of Soybean Sprouts because they may be contaminated with Listeria monocytogenes , an organism which can cause serious and sometimes fatal infections to individuals with weakened immune systems.
Flying Cow Creamery Voluntarily Recalls Yogurt
Flying Cow Creamery is voluntarily recalling one lot of whole milk yogurt due to a faulty time and temperature recording during pasteurization.
HIV Patients Not Receiving Regular Care
With new medications and treatments, HIV therapy has dramatically improved over the past two decades. Many with the virus, however, may not be getting proper treatment.
Thanksgiving Safety: From Prep to Leftovers
Can't wait to dive into that Thanksgiving feast? Well, hold on a moment. Whether you're cooking the meal or simply enjoying the leftovers the day after, there are some food safety tips you should know.
Case of Rare Brain Infection Reported in MS Patient Taking Tecfidera
FDA is warning that a patient with multiple sclerosis (MS) who was being treated with Tecfidera (dimethyl fumarate) developed a rare and serious brain infection called progressive multifocal leukoencephalopathy (PML), and later died.
Ranchers Legacy Meat Co. Recalls Ground Beef Due to Possible E. Coli
Ranchers Legacy Meat Co., of Vadnais Heights, Minn., is recalling 1,200 pounds of ground beef products that may be contaminated with E. coli O157:H7, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.
Ebola Patient Dies in Nebraska Treatment Center
A surgeon infected with Ebola in West Africa is headed to the Nebraska Medical Center in Omaha for treatment.
Thanksgiving Food Safety
One in six Americans contracts a foodborne illness in the United States each year, according to the Centers for Disease Control and Prevention (CDC). You don’t want that number to include one of your Thanksgiving guests, so don’t let cooking for a crowd lead to mistakes.
Gilead Announces Harvoni Results from Phase 2 and Phase 3 Studies
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from several Phase 2 and Phase 3 studies evaluating investigational uses of Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of chronic hepatitis C virus (HCV) infection in patients with limited or no treatment options, including patients with decompensated cirrhosis, patients with HCV recurrence following a liver transplant and patients who failed previous treatment with other direct acting antivirals.
Hepatitis C Patients May Live Longer With Treatment
For patients with chronic hepatitis C, liver problems can sometimes shorten their lives. But a new study found that successful treatment might ease some life expectancy concerns for these patients.